New Blood: Former Novartis Exec Transitions to Rubius Therapeutics
New Red-Blood-Cell-Derived Therapies Are Poised to Launch Rubius into the Spotlight.
Improving Human Health: The Promise of Epigenetics
A New Perspective for Genomic Research from Prof. Shankar Balsubramanian
Translating Innovation into Therapies
Antimicrobial Resistance and Drug Commercialization Were Key Topics at the Recent ON Helix Conference in Cambridge, U.K.
Literature Review: Dielectrophoresis to the Fore
Old Methodology Resurrected to Allow Inexpensive Label-Free Separation of Cell Populations
- Horizon Discovery
- 8100 Cambridge Research Park
- Cambridge , CB25 9TL
- UNITED KINGDOM
Horizon Discovery is a world-leading gene editing company that designs and engineers genetically-modified cells, applying them to advance human health. Horizon’s catalogue of over 23,000 models supports the understanding of the genetic drivers of disease, and underpins a broad range of services and Horizon’s own R&D pipeline.